Sierra Leone

CLICK HERE - RESEARCH - Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting

prweb.com - by Cynthia Lujan - September 1, 2015

A new host-based therapy for Ebola, anthrax and other deadly infectious diseases has been discovered by researchers at the Keck Graduate Institute and its collaborators. The discovery has the potential to speed to market treatments for previously untreatable diseases.

The findings were published online on August 27 by Scientific Reports, an open access research journal from the publishers of Nature.

The lead authors of the story were Leoor Zilberminitz and William Leonardi, doctoral students in KGI laboratory of assistant professor Mikhail Martchenko. The researchers screened a library of 1,581 drugs previously approved by the FDA for in vitro protection of mammalian cells against Bacillus anthracis lethal toxin and diphtheria toxin, which normally kill 50-70% of unprotected cells. They then investigated the 1% most promising compounds that both provided the best protection against the two toxins and were not toxic to uninfected cells.

allafrica.com - August 24, 2015

Freetown — The Guinean Ebola Ring Vaccine Trial has been extended to Sierra Leone as a move to stop the transmission across the region.

Addressing participants in the opening ceremony of the training session at the Brookfields Hotel Conference Hall in Freetown, the WHO Ebola Technical Coordinator Sierra Leone, Dr. Margaret Lamumu said prior to the extension of the vaccine to Sierra Leone the Ministry of Health and Sanitation and WHO Joint Team visited five sites to make available the vaccine study, adding that expert trainers from the UK were targeted to do the training. . . .

. . . The Chief Medical Officer, Dr. Brima Kargbo said the use of the vaccine would help break the chain of transmission, stressing the need to work collectively as a team to control the spread of the disease.

(READ COMPLETE ARTICLE)

(CLICK HERE - For Additional Information)

Ebola Situation Reports:

CLICK HERE -  Interagency Collaboration on Ebola - Situation Report - 25 August 2015 (7 page .PDF report)

CLICK HERE - WHO - Situation Report - 26 August 2015

CLICK HERE - Report Archives - Interagency Collaboration on Ebola

CLICK ON THE LINKS BELOW - Current - Report Archives - WHO
http://apps.who.int/ebola/ebola-situation-reports
http://apps.who.int/ebola/ebola-situation-reports-archive

CLICK ON THE LINK BELOW - Older Report Archives - WHO
http://www.who.int/csr/disease/ebola/situation-reports/archive/en/

link.springer.com - EcoHealth - August 13, 2015 
Siv Aina J. Leendertz, Jan F. Gogarten, Ariane Düx, Sebastien Calvignac-Spencer, Fabian H. Leendertz

CLICK HERE - Assessing the Evidence Supporting Fruit Bats as the Primary Reservoirs for Ebola Viruses

Introduction

Since their discovery 40 years ago, Ebola viruses (in the following: EBOV; family Filoviridae, genus Ebolavirus) continue to emerge unpredictably and cause Ebola virus disease (EVD) in humans and susceptible animals in tropical Africa (Leroy et al. 2004; Feldmann and Geisbert 2011). The scale of the current epidemic in West Africa demonstrates the impact that a single spillover event can have (Baize et al. 2014; Gire et al. 2014). Meanwhile, the reservoir(s) and ecology of EBOV remain largely unknown (Groseth et al. 2007; Feldmann and Geisbert 2011), hampering prediction of future outbreaks.